Autolus Therapeutics plc - American Depositary Shares, each representing one ordinary share, par value $0.000042 per share (AUTL)

Q: What does CUSIP 05280R100 represent in this 13F holders report?

CUSIP 05280R100 is the security identifier for AUTL - Autolus Therapeutics plc - American Depositary Shares, each representing one ordinary share, par value $0.000042 per share used to aggregate holder disclosures.

Q: How many institutions held AUTL - Autolus Therapeutics plc - American Depositary Shares, each representing one ordinary share, par value $0.000042 per share in Q4 2018?

36 institutional investors reported AUTL - Autolus Therapeutics plc - American Depositary Shares, each representing one ordinary share, par value $0.000042 per share for Q4 2018. Use the holders table for investor-level position and value details.

CUSIP: 05280R100

Q4 2018 13F Holders as of 31 Dec 2018

Type / Class: Equity / American Depositary Shares, each representing one ordinary share, par value $0.000042 per share
Shares outstanding: 265,957,447
Total 13F shares: 16,988,795
Share change: -864,282
Total reported value: $557,884,000
Price per share: $32.84
Number of holders: 36
Value change: -$24,061,507
Number of buys: 15
Number of sells: 30

Quarterly Holders Quick Answers

What is CUSIP 05280R100?
CUSIP 05280R100 identifies AUTL - Autolus Therapeutics plc - American Depositary Shares, each representing one ordinary share, par value $0.000042 per share in SEC institutional holdings data.

Need full ownership history?
Open the full security ownership history page.

Next holder-history checks

These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.

Back to full security ownership history for the broader multi-quarter picture.
Latest 13F filings for newly reported positions across managers.
Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
SEC investors directory for manager drilldown.

Explore More Reporting Periods

Jump to adjacent filing periods for faster comparison and easier crawl discovery.

Newer quarter: Q1 2019
Previous quarter: Q3 2018

Recent filing periods for CUSIP 05280R100:

Q1 2026 Q4 2025 Q3 2025 Q2 2025 Q1 2025 Q4 2024 Q3 2024 Q2 2024

Top shareholders of AUTL - Autolus Therapeutics plc - American Depositary Shares, each representing one ordinary share, par value $0.000042 per share (13F + 13D/G + 3/4/5)

Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.

Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.

Holder	Source	Role / Reporting	Ownership %	Shares	Holdings Value	12M Net Δ	As of	Details
Woodford Investment Management Ltd	13F	Company	4.1%	10,825,919	$332,030,000	—	30 Sep 2018	13F
Cormorant Asset Management, LP	13F	Company	0.5%	1,326,136	$40,673,000	—	30 Sep 2018	13F
Tetragon Partners GP Ltd	13F	Company	0.3%	790,150	$24,234,000	—	30 Sep 2018	13F
Alphabet Inc.	13F	Company	0.27%	714,072	$21,901,000	—	30 Sep 2018	13F
Capital World Investors	13F	Company	0.23%	611,112	$18,431,000	—	30 Sep 2018	13F
Artal Group S.A.	13F	Company	0.19%	500,000	$15,335,000	—	30 Sep 2018	13F
PRICE T ROWE ASSOCIATES INC /MD/	13F	Company	0.19%	502,761	$15,163,000	—	30 Sep 2018	13F
Capital International Investors	13F	Company	0.18%	488,888	$14,745,000	—	30 Sep 2018	13F
SPHERA FUNDS MANAGEMENT LTD.	13F	Company	0.11%	296,251	$8,935,000	—	30 Sep 2018	13F
DEERFIELD MANAGEMENT COMPANY, L.P.	13F	Company	0.09%	250,000	$7,668,000	—	30 Sep 2018	13F
BAKER BROS. ADVISORS LP	13F	Company	0.09%	235,294	$7,216,000	—	30 Sep 2018	13F
PFM Health Sciences, LP	13F	Company	0.08%	219,628	$6,736,000	—	30 Sep 2018	13F
FIL Ltd	13F	Company	0.06%	156,916	$4,732,000	—	30 Sep 2018	13F
JENNISON ASSOCIATES LLC	13F	Company	0.04%	119,190	$3,595,000	—	30 Sep 2018	13F
Granahan Investment Management, LLC	13F	Company	0.04%	100,762	$3,090,000	—	30 Sep 2018	13F
ESSEX INVESTMENT MANAGEMENT CO LLC	13F	Company	0.03%	80,138	$2,458,000	—	30 Sep 2018	13F
VICTORY CAPITAL MANAGEMENT INC	13F	Company	0.03%	78,680	$2,373,000	—	30 Sep 2018	13F
OXFORD ASSET MANAGEMENT LLP	13F	Company	0.03%	77,370	$2,353,000	—	30 Sep 2018	13F
Allianz Asset Management GmbH	13F	Company	0.02%	66,260	$2,033,000	—	30 Sep 2018	13F
Polar Capital LLP	13F	Company	0.02%	50,000	$1,534,000	—	30 Sep 2018	13F
Alyeska Investment Group, L.P.	13F	Company	0.02%	46,500	$1,426,000	—	30 Sep 2018	13F
FEDERATED HERMES, INC.	13F	Company	0.02%	46,947	$1,416,000	—	30 Sep 2018	13F
Nuveen Asset Management, LLC	13F	Company	0.01%	39,276	$1,205,000	—	30 Sep 2018	13F
MILLENNIUM MANAGEMENT LLC	13F	Company	0.01%	35,958	$1,084,000	—	30 Sep 2018	13F
Weiss Multi-Strategy Advisers LLC	13F	Company	0.01%	33,043	$1,013,000	—	30 Sep 2018	13F
PRELUDE CAPITAL MANAGEMENT, LLC	13F	Company	0.01%	30,812	$945,000	—	30 Sep 2018	13F
BLAIR WILLIAM & CO/IL	13F	Company	0.01%	30,800	$945,000	—	30 Sep 2018	13F
Laurion Capital Management LP	13F	Company	0.01%	24,190	$730,000	—	30 Sep 2018	13F
Marshall Wace North America L.P.	13F	Company	0.01%	19,811	$597,000	—	30 Sep 2018	13F
BANK OF MONTREAL /CAN/	13F	Company	0.01%	16,000	$491,000	—	30 Sep 2018	13F
Pentwater Capital Management LP	13F	Company	0.01%	13,350	$409,000	—	30 Sep 2018	13F
TD ASSET MANAGEMENT INC	13F	Company	0%	9,949	$300,000	—	30 Sep 2018	13F
NEW YORK STATE COMMON RETIREMENT FUND	13F	Company	0%	7,112	$214,000	—	30 Sep 2018	13F
BlackRock Finance, Inc.	13F	Company	0%	4,923	$151,000	—	30 Sep 2018	13F
Partner Investment Management, L.P.	13F	Company	0%	2,094	$64,000	—	30 Sep 2018	13F
Harel Insurance Investments & Financial Services Ltd.	13F	Company	0%	1,491	$46,000	—	30 Sep 2018	13F
WELLS FARGO & COMPANY/MN	13F	Company	0%	1,150	$35,000	—	30 Sep 2018	13F
UBS Group AG	13F	Company	0%	76	$2,000	—	30 Sep 2018	13F
Tower Research Capital LLC (TRC)	13F	Company	0%	68	$2,000	—	30 Sep 2018	13F

Institutional Holders of Autolus Therapeutics plc - American Depositary Shares, each representing one ordinary share, par value $0.000042 per share (AUTL) as of Q4 2018

As of 31 Dec 2018, Autolus Therapeutics plc - American Depositary Shares, each representing one ordinary share, par value $0.000042 per share (AUTL) was held by 36 institutional shareholders that filed Form 13F with the SEC. Together, they reported ownership of 16,988,795 shares. The largest 10 holders included Woodford Investment Management Ltd, Polygon Management Ltd., Alphabet Inc., Capital World Investors, PRICE T ROWE ASSOCIATES INC /MD/, Capital International Investors, Artal Group S.A., DEERFIELD MANAGEMENT COMPANY, L.P. (SERIES C), SPHERA FUNDS MANAGEMENT LTD., and BlackRock Inc.. This page lists 36 institutional shareholders reporting positions in this security for the Q4 2018 filing period.

Investor	Option	Weight %	Change %	Value $	* Price	Shares	Share Change	Activity	Report Period

Compare Q4 2018 vs Q3 2018 Across Filers

Q3 2018 holders

Q4 2018 holders

Holder diff

-3

Investor	Q3 2018 Shares	Q4 2018 Shares	Share Diff	Share Chg %	Q3 2018 Value $	Q4 2018 Value $	Value Diff $	Value Chg %

Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).

Quarterly Holders Trend

Quarterly Value Trend

Quarterly Shares Trend

* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.